NuCana PLC reports results for the quarter ended in September - Earnings Summary
Brief: NuCana Reports Third Quarter 2022 Financial Results, Provides Business Update
NuCana PLC expected to post a loss of 11 pence a share - Earnings Preview
Brief: Nucana Presents Positive Data On Nuc-3373 At The 34Th Eortc-Nci-Aacr Annual Meeting 2022
Brief: Nucana Presents Favorable Data On Nuc-3373
NuCana PLC reports results for the quarter ended in June - Earnings Summary
Brief: NuCana Reports Q2 Results And Provides Business Update
NuCana PLC expected to post a loss of 12 pence a share - Earnings Preview
Brief: NuCana Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: German Court Rules That Gilead's Sofosbuvir Infringes Nucana's 190 Patent
NuCana PLC expected to post a loss of 16 pence a share - Earnings Preview
Brief: NuCana Reports Fourth Quarter And Year Ended 2021 Financial Results
NuCana PLC reports results for the quarter ended in December - Earnings Summary
NuCana PLC expected to post a loss of 20 pence a share - Earnings Preview
NuCana dives on scrapping biliary tract cancer drug trial
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:19 PM
Brief: NuCana Reports Update for Phase 3 Biliary Tract Cancer Study
NuCana PLC expected to post a loss of 19 pence a share - Earnings Preview
Brief: NuCana Reports Q3 Loss Per Share Of GBP 0.15